Phase Forward and Lilly Extend Multi-Year Agreement
Complete the form below to unlock access to ALL audio articles.
Phase Forward has announced a multi-year extension agreement with Eli Lilly and Company.
Since 2001, Lilly has utilized Phase Forward’s InForm product in over 200 trials and plans to continue to use InForm for global trials across all phases, as well as mandating the use of the InForm product with its global service partners.
“We look forward to continuing to leverage Phase Forward as our clinical data management solution of choice,” said Jeffrey Kasher, PhD, vice president and chief operating officer of global clinical development, Eli Lilly and Company.
“Phase Forward has been a longstanding member of Eli Lilly’s Alliance Program and has been instrumental in providing Lilly with technology solutions in order to expand our global trials,” Kasher said.
“As an early adopter of EDC, Lilly has been a pioneer in leveraging technology to support clinical trials,” said Bob Weiler, Phase Forward’s CEO and president. “We are proud of the role our integrated solutions and global services have been able to play in their success and are delighted that we are able to continue this highly collaborative and valued partnership.”
